Publications 2022

Langberg NE, Jenssen TG, Haugen AJ, Mjoen G, Birkeland KI, Asberg A, Hartmann A, Dahle DO (2022)
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
Transplant. Direct., 8 (1), e1262
DOI 10.1097/TXD.0000000000001262

Publications 2021

Bjorkto MH, Barratt-Due A, Nordoy I, Dorje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjoen G (2021)
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
BMC Infect. Dis., 21 (1), 137
DOI 10.1186/s12879-021-05789-2

Dahle DO, Mjoen G (2021)
Hypertensive Living Kidney Donor Candidates: What's the Risk
Kidney Int. Rep., 6 (5), 1208-1210
DOI 10.1016/j.ekir.2021.03.891

Delanaye P, Gaillard F, van der Weijden J, Mjoen G, Ferhman-Ekholm I, Dubourg L, Ebert N, Schaeffner E, Akerfeldt T, Goffin K, Couzi L, Garrouste C, Rostaing L, Courbebaisse M, Legendre C, Hourmant M, Kamar N, Cavalier E, Weekers L, Bouquegneau A, de Borst MH, Mariat C, Pottel H, van Londen M (2021)
Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
Clin. Chem. Lab. Med.
DOI 10.1515/cclm-2021-1011

Haugen AJ, Mjoen G (2021)
Living donation - any news on the donor?
Curr. Opin. Organ Transpl., 26 (1), 85-90
DOI 10.1097/MOT.0000000000000830

Mjoen G, Maggiore U, Kessaris N, Kimenai D, Watschinger B, Mariat C, Sever MS, Crespo M, Peruzzi L, Spasovski G, Sorensen SS, Heemann U, Pascual J, Viklicky O, Courtney AE, Hadaya K, Wagner L, Nistor I, Hadjianastassiou V, Durlik M, Helantera I, Oberbauer R, Oniscu G, Hilbrands L, Abramowicz D et al. (2021)
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
Nephrol. Dial. Transplant., 36 (9), 1742-1753
DOI 10.1093/ndt/gfab035

Publications 2020

Asberg A, Bergan S, Bjorkto MH, Mjoen G, Reisaeter AV, Robertsen I, Midtvedt K (2020)
Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient-No Intervention Actually Needed
Transplant. Direct., 6 (10), e609
DOI 10.1097/TXD.0000000000001058

Benoni H, Eloranta S, Dahle DO, Svensson MHS, Nordin A, Carstens J, Mjoen G, Helantera I, Hellstrom V, Enblad G, Pukkala E, Sorensen SS, Lempinen M, Smedby KE (2020)
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Transpl. Int., 33 (12), 1700-1710
DOI 10.1111/tri.13734

Bjerre A, Mjoen G, Line PD, Naper C, Reisaeter AV, Asberg A (2020)
Five decades with grandparent donors: The Norwegian strategy and experience
Pediatr. Transplant., 24 (6), e13751
DOI 10.1111/petr.13751

Blom KB, Bergo KK, Espe EKS, Rosseland V, Grotta OJ, Mjoen G, Asberg A, Bergan S, Sanner H, Bergersen TK, Bjornerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2020)
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Pressure, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817

Dahle DO, Mjoen G (2020)
The Salutary Blood Pressure of a Solitary Kidney
Am. J. Hypertens., 33 (3), 218-219
DOI 10.1093/ajh/hpaa004

Haller MC, Wallisch C, Mjoen G, Holdaas H, Dunkler D, Heinze G, Oberbauer R (2020)
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study
Transpl. Int., 33 (7), 729-739
DOI 10.1111/tri.13580

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl. Int., 33 (5), 536-543
DOI 10.1111/tri.13576

Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B, DESCARTES Working Grp ERA-EDTA (2020)
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
Nephrol. Dial. Transplant., 35 (6), 899-904
DOI 10.1093/ndt/gfaa130

Pihlstrom HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarstrom C, Kasprzycka M, Wang JB, Haraldsen G, Mjoen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H (2020)
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
PLoS One, 15 (12), e0243759
DOI 10.1371/journal.pone.0243759

Thorsteinsdottir H, Salvador CL, Mjoen G, Lie A, Sugulle M, Tondel C, Brun A, Almaas R, Bjerre A (2020)
Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation
Dis. Markers, 2020, 6162892
DOI 10.1155/2020/6162892

Publications 2019

Haugen AJ, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl. Int., 32 (9), 960-964
DOI 10.1111/tri.13443

Mjoen G, Abramowicz D (2019)
What happens to the live donor in the years following donation?
Nephrol. Dial. Transplant., 34 (8), 1289-1291
DOI 10.1093/ndt/gfy356

Mjoen G, Reisaeter A, Hartmann A, Dahle DO, Holdaas H (2019)
Regarding age-calibrated glomerular filtration rate
Kidney Int., 95 (1), 234-235
DOI 10.1016/j.kint.2018.10.003

Pihlstrom HK, Mjoen G, Mucha S, Franke A, Jardine A, Fellstrom B, Dahle DO, Holdaas H, Melum E (2019)
Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
Am. J. Transplant., 19 (5), 1444-1451
DOI 10.1111/ajt.15191

Publications 2018

Mjoen G, Holdaas H (2018)
Mid- and Long-Term Health Risks in Living Kidney Donors
Ann. Intern. Med., 169 (4), 265
DOI 10.7326/L18-0340

Solbu MD, Mjoen G, Mark PB, Holdaas H, Fellstrom B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
Nephrol. Dial. Transplant., 33 (1), 102-112
DOI 10.1093/ndt/gfw360

Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisaeter AV, Mjoen G, Pihlstrom HK, Naess H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659

Holdaas H, Mjoen G, Jardine AG (2017)
Belatacept: Where the BENEFITS Outweigh the Risk
Am. J. Kidney Dis., 69 (5), 561-563
DOI 10.1053/j.ajkd.2017.02.007

Meyer KB, Hartmann A, Mjoen G, Andersen MH (2017)
Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
Ann. Transpl., 22, 148-155
DOI 10.12659/AOT.902330

Mjoen G, Holdaas H (2017)
Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
Kidney Int., 91 (5), 1256
DOI 10.1016/j.kint.2017.01.034

Norby GE, Mjoen G, Bjorneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarod K (2017)
Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
Lupus, 26 (8), 881-885
DOI 10.1177/0961203316686700

Pihlstrom HK, Gatti F, Hammarstrom C, Eide IA, Kasprzycka M, Wang JB, Haraldsen G, Svensson MHS, Midtvedt K, Mjoen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl. Int., 30 (8), 827-840
DOI 10.1111/tri.12973

Pihlstrom HK, Mjoen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellstrom B, Holdaas H, Melum E (2017)
Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
Am. J. Transplant., 17 (2), 528-533
DOI 10.1111/ajt.13995

Smedbraten J, Sagedal S, Aring;sberg A, Hartmann A, Rollag H, Mjoen G, Fagerland MW, Hansen SWK, Mollnes TE, Thiel S (2017)
Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
Am. J. Transplant., 17 (1), 265-271
DOI 10.1111/ajt.13933

Publications 2016

Dorje C, Reisaeter AV, Dahle DO, Mjoen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin. Transplant., 30 (7), 802-809
DOI 10.1111/ctr.12753

Mjoen G, Holdaas H (2016)
Regarding long-term outcome after kidney donation
Transpl. Int., 29 (3), 381
DOI 10.1111/tri.12717

Mjoen G, Holdaas H (2016)
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
N. Engl. J. Med., 374 (21), 2094

Mjoen G, Reisaeter AV, Dahle DO (2016)
HLA Mismatch and Allograft Survival
Transplantation, 100 (9), E52
DOI 10.1097/TP.0000000000001366

Smedbraten J, Mjoen G, Hartmann A, Asberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol., 17, 148
DOI 10.1186/s12882-016-0373-9

Publications 2015

Dahle DO, Eide IA, Asberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrom H, Mjoen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-1737
DOI 10.1097/TP.0000000000000660

Dorje C, Mjoen G, Strom EH, Holdaas H, Jenssen T, Oyen O, Akkok CA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Clin. Transplant., 29 (3), 268-276
DOI 10.1111/ctr.12515

Mjoen G, Holdaas H (2015)
Selecting Appropriate Controls for Kidney Donors
Am. J. Transplant., 15 (1), 286
DOI 10.1111/ajt.13016

Mjoen G, Holdaas H (2015)
Regarding 'Long-term risks for kidney donors' Reply
Kidney Int., 87 (3), 660
DOI 10.1038/ki.2014.400

Pihlstrom H, Dahle DO, Mjoen G, Pilz S, Marz W, Abedini S, Holme I, Fellstrom B, Jardine AG, Holdaas H (2015)
Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism
Transplantation, 99 (2), 351-359
DOI 10.1097/TP.0000000000000583

Smedbraten YV, Sagedal S, Mjoen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High Ficolin-3 Level at the Time of Transplantation Is an Independent Risk Factor for Graft Loss in Kidney Transplant Recipients
Transplantation, 99 (4), 791-796
DOI 10.1097/TP.0000000000000422

Publications 2014

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjoen G, Eide IA, Pihlstrom H, Doerje C, Halden TAS, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin. Transplant., 28 (10), 1167-1176
DOI 10.1111/ctr.12435

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vardal M, Mjoen G, Reisaeter AV, Toft I, Hartmann A (2014)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin. Transplant., 28 (1), 134-140
DOI 10.1111/ctr.12290

Holdaas H, Mjoen G (2014)
Long-Term Risks of Kidney Donation: Age Known
Am. J. Transplant., 14 (11), 2671-2672
DOI 10.1111/ajt.12971

Mjoen G (2014)
Increasing mortality by living kidney donation ?: The devil is in the details Reply
Kidney Int., 85 (6), 1469
DOI 10.1038/ki.2014.91

Mjoen G, Hallan S, Dekker FW, Holdaas H (2014)
Kidney donors at increased risk? Additional studies are needed Reply
Kidney Int., 86 (3), 650
DOI 10.1038/ki.2014.148

Mjoen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O, Reisaeter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Ovrehus M, Dale DO, PihIstrom H, Holme I, Dekker FW, Holdaas H (2014)
Long-term risks for kidney donors
Kidney Int., 86 (1), 162-167
DOI 10.1038/ki.2013.460

Mjoen G, Hallan S, Holdaas H (2014)
The importance of selecting controls in kidney donor outcome studies Reply
Kidney Int., 85 (5), 1241-1242
DOI 10.1038/ki.2014.37

Mjoen G, Holdaas H (2014)
Long-term risks for kidney donors Reply
Kidney Int., 86 (2), 447
DOI 10.1038/ki.2014.149

Pihlstrom H, Mjoen G, Dahle DO, Pilz S, Midtvedt K, Marz W, Abedini S, Holme I, Fellstrom B, Jardine A, Holdaas H (2014)
Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients
Transplantation, 98 (11), 1219-1225
DOI 10.1097/TP.0000000000000205

Pihlstrom H, Mjoen G, Marz W, Dahle DO, Abedini S, Holme I, Fellstrom B, Jardine A, Pilz S, Holdaaas H (2014)
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
Clin. Transplant., 28 (1), 111-119
DOI 10.1111/ctr.12285

Smedbraten YV, Sagedal S, Leivestad T, Mjoen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2014)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin. Transplant., 28 (1), 120-126
DOI 10.1111/ctr.12288

Publications 2013

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjoen G, Leivestad T, Asberg A (2013)
Endothelial Dysfunction Is Associated With Graft Loss in Renal Transplant Recipients
Transplantation, 95 (5), 733-739
DOI 10.1097/TP.0b013e31827d6312

Schjelderup P, Dahle DO, Holdaas H, Mjoen G, Nordby G, Abedini S, Jardine A, Fellstrom B, Svensson M (2013)
Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
Clin. Transplant., 27 (6), E636-E643
DOI 10.1111/ctr.12220

Publications 2012

Mjoen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2012)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol. Dial. Transplant., 27 (1), 443-447
DOI 10.1093/ndt/gfr303

Svensson M, Dahle DO, Mjoen G, Weihrauch G, Scharnagl H, Dobnig H, Marz W, Jardine A, Fellstrom B, Holdaas H (2012)
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study
Nephrol. Dial. Transplant., 27 (6), 2571-2575
DOI 10.1093/ndt/gfr694

Publications 2011

Dahle DO, Mjoen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, Marz W, Abedini S, Norby GE, Holme I, Fellstrom B, Jardine A, Holdaas H (2011)
Inflammation-associated graft loss in renal transplant recipients
Nephrol. Dial. Transplant., 26 (11), 3756-3761
DOI 10.1093/ndt/gfr163

Mjoen G, Midtvedt K, Holme I, Oyen O, Fauchald P, Bergrem H, Holdaas H (2011)
One- and five-year follow-ups on blood pressure and renal function in kidney donors
Transpl. Int., 24 (1), 73-77
DOI 10.1111/j.1432-2277.2010.01148.x

Mjoen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
Age, gender, and body mass index are associated with renal function after kidney donation
Clin. Transplant., 25 (6), E579-E583
DOI 10.1111/j.1399-0012.2011.01503.x

Mjoen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
Quality of Life in Kidney Donors
Am. J. Transplant., 11 (6), 1315-1319
DOI 10.1111/j.1600-6143.2011.03517.x

Norby GE, Gunther A, Mjoen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
RHEUMATOLOGY, 50 (9), 1659-1664
DOI 10.1093/rheumatology/ker186

Norby GE, Leivestad T, Mjoen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature Cardiovascular Disease in Patients With Systemic Lupus Erythematosus Influences Survival After Renal Transplantation
Arthritis Rheum., 63 (3), 733-737
DOI 10.1002/art.30184

Publications 2010

Mjoen G, Holdaas H, Pfeffer P, Line PD, Oyen O (2010)
Minimally invasive living donor nephrectomy - introduction of hand-assistance
Transpl. Int., 23 (10), 1008-1014
DOI 10.1111/j.1432-2277.2010.01087.x

Publications 2009

Mjoen G, Oyen O, Holdaas H, Midtvedt K, Line PD (2009)
Morbidity and Mortality in 1022 Consecutive Living Donor Nephrectomies: Benefits of a Living Donor Registry
Transplantation, 88 (11), 1273-1279
DOI 10.1097/TP.0b013e3181bb44fd